HONG KONG -- When it comes to China and biotechnology, U.S. policy is influenced by a mix of economic considerations, geopolitical issues, reasonable fears and excessive paranoia. All were on display at a congressional committee hearing on the subject in Washington last year.
The Big Story
China and the new frontier of biosecurity threats
Security experts warn of 'biological extortion' and other emerging risks
